Description
Artraksikam Pharmacodynamics
Artraksikam has anti-inflammatory, analgesic, anti-edema effect. May cause slight local hyperemia of the skin, while not having a pronounced irritating effect on the skin.
Artraksikam reduces pain in joints (including spinal joints) and muscles at rest and when moving, helps to increase joint movement (in the area of application of the cream). Reduces morning stiffness and swelling of the joints.
Meloxicam selectively inhibits cyclooxygenase 2, disrupts the metabolism of arachidonic acid, reduces the amount of prostaglandins (mediators of pain and inflammation) in the inflammation.
Tincture of chilli pepper contains capsaicin, which has an irritating effect on sensitive skin receptors, which leads to local analgesic effect, to improve blood circulation in the skin and subcutaneous tissue. Improvement of local blood flow is accompanied by increased blood circulation in the underlying tissues, which contributes to the removal of the substrate of inflammation from the pathological focus.
When combined effect meloxicam and capsaicin have a greater effect due to synergism compared with the individual effect of each of these components. Due to the optimal combination of components, Arthraxicam has an enhanced analgesic and anti-inflammatory effect.
Indications
Inflammatory and degenerative diseases of the musculoskeletal system.
Rheumatic soft tissue lesions.
Pain syndrome: bursitis, tendinitis, lumbago, sciatica, neuralgia, myalgia, arthralgia, radiculitis, post-traumatic pain syndrome (traumatic bruises, sprains, ligament, muscle and tendon strains, muscle tears without skin integrity disorders), pain in muscles and joints caused by hard physical exercises.
Contraindications .
Hypersensitivity to the drug components, children (under 12 years), violations of the integrity of the skin and inflammatory skin conditions at the site of intended application.
Caution
Impaired renal and hepatic function, marked gastrointestinal tract pathology (gastric and 12 duodenal ulcer in the acute phase), marked pathology of the blood system, in childhood (12 to 18 years).
It is necessary to consult with a physician before using Artraksikam cream together with other non-steroidal anti-inflammatory drugs, as well as if the drug must be used for more than 10 days.
Administration during pregnancy and lactation
The drug is contraindicated in pregnancy and lactation.
Dosage and administration
- Outwardly.
- Lightly rubbing a strip of cream length of 1 to 5 cm, the frequency of use – 1 – 3 times a day.
- The amount of cream and frequency of use may vary depending on the area of application and individual response to the cream.
- To enhance the effect you can apply a dry warming bandage.
